Gmt Capital Corp Royalty Pharma PLC Transaction History
Gmt Capital Corp
- $2.38 Billion
- Q2 2024
A detailed history of Gmt Capital Corp transactions in Royalty Pharma PLC stock. As of the latest transaction made, Gmt Capital Corp holds 2,427,100 shares of RPRX stock, worth $65.9 Million. This represents 2.69% of its overall portfolio holdings.
Number of Shares
2,427,100
Previous 1,809,900
34.1%
Holding current value
$65.9 Million
Previous $55 Million
16.44%
% of portfolio
2.69%
Previous 2.21%
Shares
4 transactions
Others Institutions Holding RPRX
# of Institutions
405Shares Held
291MCall Options Held
305KPut Options Held
138K-
Morgan Stanley New York, NY44.1MShares$1.2 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA38MShares$1.03 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$625 Million0.01% of portfolio
-
Baillie Gifford & CO16.4MShares$444 Million0.34% of portfolio
-
Viking Global Investors LP12MShares$325 Million1.26% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $11.9B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...